Medical News Today: Modified herpes virus effective against late-stage melanoma
A new treatment with a genetically modified herpes virus is effective against stage 3B and stage 4 melanoma, a recent human study confirms. A genetically modified herpes virus is demonstrably effective against stage 3 melanoma, researchers show. In 2015, the United States Food and Drug Administration (FDA) approved the use of talimogene laherparepvec (TVEC) for…